COPD Specialists in Washington

Links shared publicly online about this topic

COPD and Other Stuff » Blog Archive » The University of Washington Rocks!

pugetsoundblogs.com — “The University of Washington is a God send to us. I wrote the following in answer to a letter to the editor and decided to add it here as well. "The University of Washington 'elitist'? If 'elitist' means dedicated fine professors teaching a subject they they live their work.View full resource at pugetsoundblogs.com

  • View Related
  • Share

Most Recently Shared on June 16, 2010 at 5:48 pm By:

UWMedicineNews UW Medicine News Hospital

UW rocks, blogs patient: Thanks for all you do for us.. to make next generation lung patients fewer, living quality lives http://ow.ly/1Znuk

2 years ago...

COPD Foundation Raises Awareness During COPD Week at ATS | Business Wire

businesswire.com — “The COPD Foundation and the American Thoracic Society (ATS) will host “COPD Week at the ATS” to bring awareness to Chronic Obstructive PulView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on November 10, 2011 at 3:24 pm By:

Lung_Breathing Lungs and Breathing OW Health

COPD Foundation Raises Awareness During COPD Week at ATS: WASHINGTON--(BUSINESS WIRE)--The COPD Foundation and t... http://t.co/LjoI1fKd

7 months ago...

Medical News: FDA Okays New Indication for COPD Inhaler - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has expanded the approved indications for inhaled tiotropium bromide (Spiriva) to include reducing exacerbations of chronic obstructive pulmonary disease (COPD), in addition to iView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 18, 2009 at 7:09 pm By:

medical_tweets medical_tweets Health News

FDA Okays New Indication for COPD Inhaler WASHINGTON (MedPage Today) -- The FDA has expanded the approved indications.. http://bit.ly/60RxSR

2 years ago...

Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 5:28 pm By:

Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 4:50 pm By:

Medical News: FDA Panel to Vote on Approval, Dosing for COPD Drug - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- An FDA advisory panel will vote Tuesday on whether a novel long-acting beta-adrenergic agonist is safe and effective at treating airflow obstruction in patients with chronic obstructiveView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 7, 2011 at 10:46 pm By:

MedicalNews Medical News Health News

FDA Panel to Vote on Approval, Dosing for COPD Drug http://bit.ly/eLAWdN

1 year ago...

Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, thView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 10:11 pm By:

Medical News: FDA Panel to Vote on Approval, Dosing for COPD Drug - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- An FDA advisory panel will vote Tuesday on whether a novel long-acting beta-adrenergic agonist is safe and effective at treating airflow obstruction in patients with chronic obstructiveView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 8, 2011 at 3:07 pm By:

JohnCFierce John Carroll Health Communicator

FDA advisory panel meets on Novartis' COPD drug indicatarol today. Key question centers on dosage in second review. http://bit.ly/eB0RXx

1 year ago...

Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, thView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 10:13 pm By:

Pulmonary specialist seeks to raise awareness of COPD - MinotDailyNews.com | News, sports, business, jobs - Minot Daily News

minotdailynews.com — “Chronic Obstructive Pulmonary Disorder is a fatal disease that is highly preventable, according to Dr.View full resource at minotdailynews.com

  • View Related
  • Share

Most Recently Shared on November 18, 2010 at 8:15 pm By:

Lung_Breathing Lungs and Breathing OW Health

Pulmonary specialist seeks to raise awareness of COPD: Chronic Obstructive Pulmonary Disorder is a fatal disease... http://bit.ly/9J9ZNU

2 years ago...

Low-dose Azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin COPD subjects - HODGE - Respirology - Wiley Online Library

onlinelibrary.wiley.com — “Low-dose Azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin COPD subjects - HODGE - Respirology - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 11:49 am By:

JuanCIvancevich Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician

Long term use of low dose azithromycin as an attractive adjunct treatment option for COPD. http://t.co/7n2qaGUU

2 months ago...

New Inhaler Drug for COPD Approved - QualityPoint Technologies

qualitypointtech.net — “WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, the agency announced.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 11:00 pm By:

MedicalFeed MedicalFeed Health News Feed

New Inhaler Drug for COPD Approved: WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol... http://bit.ly/iGWeAq

11 months ago...

Health Professionals Training - American Lung Association

lungusa.org — “We offer may training opportunities thoughout the year including Asthma Educators Institute and COPD Educators Institute.View full resource at lungusa.org

  • View Related
  • Share

Most Recently Shared on November 17, 2010 at 7:35 pm By:

lungne ALA of New England Health Organization

Today, @lungne is hosting the #COPD Symposium to educate health professionals in West Hartford, #CT http://bit.ly/aFjdym #WorldCOPDday

2 years ago...

Ipratropium Bromide May Increase Risk For Cardiovascular Events

medicalnewstoday.com — “Patients taking ipratropium bromide, an anticholinergic used in the treatment of copd, may be at an increased risk for cardiovascular events (cve), including heart failure. researchers from the uView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 7, 2010 at 11:12 am By:

mnt_cardiovasc MNT Cardiovascular Health News

Ipratropium Bromide May Increase Risk For Cardiovascular Events http://mnt.to/3vZh

2 years ago...

UPDATE 2-US FDA staff focus on safety of Forest lung drug | Reuters

reuters.com — “* Drug worked to treat chronic lung disease-FDA staff* Uncertain signals about heart safety with drug* FDA advisory panel to review drug on ThursdayBy Anna YukhananovWASHINGTON, Feb 21 (Reuters) -View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on February 21, 2012 at 2:24 pm By:

FiercePharma FiercePharma Health Site

RT @JohnCFierce: FDA regulators like Forest COPD drug's efficacy, but raise questions on cardio risks for the class. http://t.co/qxyBK25k

3 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390